actilyse stungulyfs-/innrennslisstofn og leysir, lausn
boehringer ingelheim international gmbh* - alteplasum inn - stungulyfs-/innrennslisstofn og leysir, lausn
cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml
santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml
maxalt smelt frostþurrkuð tafla 10 mg
n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg
rizatriptan alvogen (rizatriptan portfarma) munndreifitafla 10 mg
alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg
rizatriptan alvogen (rizatriptan portfarma) munndreifitafla 5 mg
alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 5 mg
rizatriptan sumar pharma (rizatriptan ratiopharm) munndreifitafla 10 mg
alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg
sumatriptan bluefish tafla 50 mg
bluefish pharmaceuticals ab - sumatriptanum súkkínat - tafla - 50 mg
xylocain húðúði, lausn 100 mg/ml
aspen pharma trading limited - lidocainum inn - húðúði, lausn - 100 mg/ml
dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml
alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml
abilify maintena
otsuka pharmaceutical netherlands b.v. - aripíprazól - geðklofa - psycholeptics - viðhald meðferð geðklofa í fullorðinn sjúklingar stöðug með inntöku sjúklingum.